a public good project by the
Synthesis
Company
of California

© 2026

Romas Geleziunas | doi.page

0 works0 citations0 h-index

Romas Geleziunas

Gilead Sciences (United States)(US)Gilead Sciences (France)(FR)

Publications by Year

Research Areas

HIV Research and Treatment, HIV/AIDS drug development and treatment, Immune Cell Function and Interaction, HIV/AIDS Research and Interventions, NF-κB Signaling Pathways

Most-Cited Works

→ Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys(2014)626 cited
→ B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers(2015)473 cited
→ HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell(2001)320 cited
→ Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys(2018)314 cited
→ Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing(2014)279 cited
→ Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys(2016)270 cited

→ Protein Kinase C-θ Participates in NF-κB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IκB Kinase β(2000)

262 cited

→ A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor(1998)228 cited

→ Human T-Cell Leukemia Virus Type 1 Tax Induction of NF-κB Involves Activation of the IκB Kinase α (IKKα) and IKKβ Cellular Kinases(1998)220 cited

→ The Proto-Oncogene Cot Kinase Participates in CD3/CD28 Induction of NF-κB Acting through the NF-κB-Inducing Kinase and IκB Kinases(1999)206 cited